Technology News and Research

RSS

ThermoGenesis announces distribution agreement for bone marrow stem cell device

ThermoGenesis Corp. announced today it has signed a distribution agreement with Celling Technologies for ThermoGenesis' MarrowXpress (MXP(TM)) product line used for isolating stem cells from bone marrow. The distribution rights are for the field of use in orthopedic intraoperative or point-of-care applications.

9 Sep 2008

Presidential candidates discuss proposals for health care, other issues at AARP convention

Democratic presidential nominee Sen. Barack Obama (Ill.) and Republican presidential nominee Sen. John McCain (Ariz.) on Saturday appeared via satellite at an AARP convention in Washington, D.C., and spoke about health care and other issues that affect seniors, the Washington Post reports.

9 Sep 2008

VivaGel coated condoms - Starpharma and SSL International in business

Starpharma Holdings Limited has announced that a full licence agreement has been signed with SSL International plc in relation to the VivaGel coated condom. SSL manufactures and sells Durex condoms, the market-leading condom brand worldwide.

9 Sep 2008

World's first hand-held ultrasound imaging device

Siemens Canada Limited has partnered with Vancouver General Hospital (VGH) to implement the new ACUSON P10 ultrasound system - the world's first hand-held ultrasound imaging device - replacing the existing technology.

8 Sep 2008

New coating for urinary catheters reduce infection risk

A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Prentis slams 'flawed' private finance initiative

UNISON is calling on the government to abandon its failed private finance initiative (PFI) policy following the latest report from parliament's public spending watchdog.

8 Sep 2008

Johns Hopkins to assist practices in Medicare medical home demonstration

The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health has received a $1.7 million grant from the John A. Hartford Foundation to help primary care practices improve the quality and outcomes of health care for older adults with chronic illnesses.

8 Sep 2008

Binge drinking women often engage in risky sex

According to new research from the U.S., women who binge drink are more likely to indulge in unsafe sex.

8 Sep 2008

Ugandan text messaging program aims to increase awareness, knowledge of HIV/AIDS

A text messaging program using mobile phone technology is being used in western Uganda to increase awareness of and knowledge about HIV/AIDS, IRIN/Plus News reports.

7 Sep 2008

Effectiveness of Mediterranean diet confirmed for chronic disease prevention

It is effective in chronic diseases such as cardiovascular diseases, cancer, diabetes, hypertension or osteoporosis. Experts have insisted that it is possible to prevent 80% cardiovascular diseases and 40% different types of cancer through diet, physical exercise and other healthy habits. Scientists of the UGR are specifically analysing how cells react against aggressions which cause pancreatic alterations and result in cancer.

7 Sep 2008

NIH tackles urologic chronic pelvic pain disorders

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.

7 Sep 2008

Georgia Institute of Technology receives EPA safe drinking water research grant

The U.S. Environmental Protection Agency announced the award of a $600,000 research grant to Georgia Tech to improve the detection of known and emerging drinking water contaminants; including the harmful substances produced by blue-green algae in algal blooms and noroviruses.

4 Sep 2008

African countries commit to new meningitis vaccine

Health ministers from countries of the African meningitis belt today committed themselves to introduce a highly promising candidate meningitis vaccine. The vaccine is designed to prevent periodic epidemics of the deadly disease in these countries.

4 Sep 2008

Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers

Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.

4 Sep 2008

Invitrogen launches patent licensing program for random prime amplification of nucleic acids

Invitrogen Corporation today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and Kirkegaard & Perry Laboratories, Inc. (KPL), whereby the companies have licensed Invitrogen's patented technology covering the random prime amplification of nucleic acids. Financial terms of the agreements were not disclosed.

4 Sep 2008

Africa can successfully fight malaria with increased resources, commitment, WHO Director General says

Africa can achieve success in combating malaria and other diseases with sufficient resources and increased commitment from African leaders, World Health Organization Director-General Margaret Chan said Monday at the opening of the 58th session of WHO's Regional Committee for Africa in Yaounde, Cameroon, the Cameroon Tribune reports.

4 Sep 2008

President Bush signs law to ensure health benefits for 'sole survivor' veterans

President Bush on Friday signed into law legislation (HR 5825, S 2874) that will guarantee health benefits for "sole survivor" veterans who receive honorable discharges, the Los Angeles Times reports.

4 Sep 2008

Anadis to commercialise "BioGard" adjunctive therapy for HIV/AIDS

Anadis announced today its commercialization of a new product, BioGard, intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.

4 Sep 2008

Clinical trial advances cystic fibrosis therapy

Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.

4 Sep 2008

Panacea Pharmaceuticals issued U.S. patent for anti-HAAH antibodies

Panacea Pharmaceuticals, Inc. has announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta-hydroxylase (HAAH), a proprietary human cancer biomarker and therapeutic target.

3 Sep 2008